| Relationship Between Fungal Colonization and Severe Bronchopulmonary Dysplasia (NCT05152875) | Centre Hospitalier Sud Francilien | 2022-03-21 |
| An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection (NCT05202366) | CAGE Bio Inc. | 2022-02-08 |
| Multicenter Cohort Study of Invasive Fungal Filamentous Fungal Infections in Liver Transplant Patients (NCT05150327) | University Hospital, Strasbourg, France | 2021-10-29 |
| Microbiota in Skin and Mucosa of Patients With Inflammatory Skin Diseases (NCT04215458) | Zealand University Hospital | 2021-09-01 |
| COVID-19 Associated Pulmonary Aspergillosis (CAPA) and Other Invasive Fungal Infections (IFI) (NCT04818853) | University of Alabama at Birmingham | 2021-03-09 |
| Fungal Infection in Patients in Intensive Care Units (NCT04684342) | Assiut University | 2021-01-01 |
| Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (NCT04368559) | Mundipharma Research Limited | 2020-05-11 |
| Itraconazole Oral Absorption (NCT04035187) | University of Maryland, Baltimore | 2020-02-10 |
| Effect of Administration of Combined Enteral Lactoferrin and Probiotic On Invasive Fungal Infections In Preterm Neonates (NCT05283278) | Ain Shams University | 2020-02-10 |
| Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (NCT04273178) | Shanghai Jiao Tong University School of Medicine | 2020-01-15 |
| ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects (NCT04307082) | Scynexis, Inc. | 2019-12-05 |
| Safety and Pharmacokinetics of Rezafungin (NCT04117607) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-12-04 |
| Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants (NCT03717623) | Melbourne Health | 2019-08-01 |
| Study to Optimize the Use of New Antibiotics (NCT03941951) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2019-07-09 |
| The PK/PD of Deoxycholic Acid Amphotericin B in Invasive Fungal Infection Patients With Sepsis/Septic Shock (NCT05642624) | Southeast University, China | 2019-02-28 |
| Efflux Pump Mediated Azole Resistance in Candida Albicans (NCT03659162) | Assiut University | 2019-02-17 |
| PTX3-targeted Antifungal Prophylaxis (NCT03828773) | Bochud Pierre-Yves | 2019-02-11 |
| Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis (NCT03814343) | Mahidol University | 2019-01-15 |
| Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis (NCT03667690) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-10-07 |
| Fungal Infections in Patients With Hematological Malignancies (NCT03650439) | Assiut University | 2018-10-01 |
| Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin (NCT03857399) | Cttq | 2018-09-17 |
| Ampholipad Real-World Data in Taiwan (NCT03641131) | Taiwan Liposome Company | 2018-09-09 |
| A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen (NCT03760276) | Seoul National University Hospital | 2018-08-20 |
| A Study to Assess the Mass Balance Recovery and Metabolite Profile & Identification of [14C]-APX001 in Healthy Males (NCT04804059) | Basilea Pharmaceutica | 2018-08-17 |
| Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant (NCT03561415) | Bayside Health | 2018-07-02 |
| Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole (NCT03434704) | Ciceri Fabio | 2018-06-18 |
| Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients (NCT03318159) | Seoul National University Hospital | 2018-04-20 |
| Pharmacokinetics of Caspofungin (NCT03399032) | Medical University of Lublin | 2018-02-05 |
| Pharmacokinetics and Safety of Intravenous Posaconazole (MK-5592) in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-120) (NCT03336502) | Merck Sharp & Dohme LLC | 2017-12-20 |
| Systemic Fungal Infections in ICU Patients (NCT03292224) | Assiut University | 2017-09-28 |
| Safety, Pharmacokinetics, Bioavailability, Food Effect, Drug-Drug Interaction Study of APX001 Administered Orally (NCT02957929) | Basilea Pharmaceutica | 2016-10-31 |
| CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (NCT02734862) | Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2016-07-26 |
| Vfend Special Investigation For Prophylaxis (NCT02674685) | Pfizer | 2016-03-11 |
| The Study of Voriconazole Trough Level in the First Two Weeks After Administration in King Chulalongkorn Memorial Hospital. (NCT03260634) | Chulalongkorn University | 2016-01-01 |
| Pharmacokinetics and Safety of Oral Posaconazole (MK-5592)Tablets in Chinese Participants at High Risk for Invasive Fungal Infections (MK-5592-117) (NCT02387983) | Merck Sharp & Dohme LLC | 2015-05-06 |
| Study to Evaluate Outcomes of Patients Receiving Treatment for Wound Care, Pain Management or Surface Skin Scar Therapy (NCT02445235) | Bracane Company | 2015-04-01 |
| MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients (NCT02227797) | Masonic Cancer Center, University of Minnesota | 2015-01-19 |
| Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE) (NCT02154178) | University Hospital, Lille | 2014-07-01 |
| Effect of Inflammation on Voriconazole Concentration (NCT02074462) | University Medical Center Groningen | 2014-01-01 |
| Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant (NCT01503515) | Children's Oncology Group | 2013-03-21 |
| A Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (MK-5592-105) (NCT01667107) | Merck Sharp & Dohme LLC | 2013-01-23 |
| Empirical Versus Preemptive Antifungal Therapy (NCT01288378) | European Organisation for Research and Treatment of Cancer - EORTC | 2012-03-01 |
| A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing (NCT01416025) | Johns Hopkins University | 2012-01-01 |
| Investigation of Clinical Relevance of β-D-Glucan Tests in Patients With Invasive Fungal Infection (IFI) (NCT01490138) | Ruijin Hospital | 2012-01-01 |
| Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients (NCT01303549) | Fundacion SEIMC-GESIDA | 2011-11-01 |
| Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients (NCT01419678) | University of Pittsburgh | 2011-10-01 |
| Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation (NCT01371656) | Children's Oncology Group | 2011-09-01 |
| Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis (NCT01318148) | Werner J. Heinz | 2011-04-01 |
| Pharmacokinetics/Pharmacodynamics (PK/PD) of Fluconazole in Children on Extracorporeal Membrane Oxygenation (ECMO) (NCT01169402) | Michael Cohen-Wolkowiez | 2010-07-01 |
| Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis (NCT01101386) | University of Colorado, Denver | 2010-05-01 |
| Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520) (NCT01075984) | Merck Sharp & Dohme LLC | 2010-02-23 |
| Effect of Weight and/or Obesity on Caspofungin Drug Concentrations (NCT01062165) | Texas Tech University Health Sciences Center | 2010-02-01 |
| Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia (NCT00936117) | M.D. Anderson Cancer Center | 2009-09-01 |
| Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis (NCT00904995) | M.D. Anderson Cancer Center | 2009-05-01 |
| Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir (NCT00817765) | Radboud University Medical Center | 2009-01-01 |
| Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients (NCT00430469) | AM-Pharma | 2008-11-01 |
| Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551) (NCT00811642) | Merck Sharp & Dohme LLC | 2008-11-01 |
| TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects. (NCT00740389) | Tibotec Pharmaceuticals, Ireland | 2008-09-01 |
| A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED) (NCT00717860) | Merck Sharp & Dohme LLC | 2008-08-01 |
| A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066) (NCT00635648) | Merck Sharp & Dohme LLC | 2008-01-01 |
| Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) (NCT00686543) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Alternate Day Micafungin: A PK Study in Pediatric Patients (NCT00842504) | Children's Hospital Medical Center, Cincinnati | 2007-07-01 |
| An Assessment of Voriconazole Pharmacokinetics and Pharmacogenetics in Liver Transplant Recipients - Pilot Study (NCT00371605) | University of Pittsburgh | 2006-12-01 |
| ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia (NCT00386997) | Gilead Sciences | 2006-11-01 |
| Evaluate the Safety and Efficacy of Caspofungin Acetate as Empirical Therapy in Chinese Adults With Persistent Fever and Neutropenia (0991-055) (NCT00548080) | Merck Sharp & Dohme LLC | 2006-03-01 |
| Emerging Invasive Fungal Infections in Critically Ill Patients (NCT04647539) | University Hospital, Montpellier | 2006-01-01 |
| Fluconazole Pharmacokinetics in Infants (NCT00514358) | Children's Hospital of Philadelphia | 2005-11-01 |
| Invasive Fungal Infections Surveillance Initiative (NCT00177944) | University of Pittsburgh | 2005-08-01 |
| A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia (0991-053)(COMPLETED) (NCT00379964) | Merck Sharp & Dohme LLC | 2005-06-01 |
| Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy (NCT00136968) | Pfizer | 2005-04-01 |
| Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 (NCT00177749) | University of Pittsburgh | 2004-08-01 |
| Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042) (NCT00292071) | Merck Sharp & Dohme LLC | 2004-05-01 |
| Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia (NCT02544230) | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | 2004-01-01 |
| Prophylaxis With Caspofungin in High-Risk Liver Transplantation (NCT00333645) | Grupo de Estudio de Infecciones en Transplantados | 2003-10-01 |